8-K 1 a10-13606_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 2, 2010

 

EXACT SCIENCES CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

000-32179

 

02-0478229

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)

 

441 Charmany Drive

Madison, WI  53719

(Address of Principal Executive Offices)(Zip Code)

 

Registrant’s telephone number, including area code: (608) 284-5700

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01 Other Events

 

Exact Sciences Corporation (the “Company”) maintains the 1995 Stock Option Plan, the 2000 Stock Option and Incentive Plan and the 2000 Employee Stock Purchase Plan. In the footnotes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the Securities and Exchange Commission on March 12, 2010 the Company reported restricted stock and stock option award information on a combined basis.  The following table supplements this information by separately showing restricted stock and stock option awards under these plans for the years ended December 31, 2009, December 31, 2008 and December 31, 2007:

 

Options and Restricted Stock

 

Options

 

Restricted Stock

 

Total

 

Outstanding, January 1, 2007

 

4,125,940

 

—

 

4,125,940

 

Granted

 

1,277,000

 

85,000

 

1,362,000

 

Exercised

 

(88,237

)

(66,249

)

(154,486

)

Cancelled

 

(1,336,766

)

—

 

(1,336,766

)

Outstanding, December 31, 2007

 

3,977,937

 

18,751

 

3,996,688

 

 

 

 

 

 

 

 

 

Granted

 

573,600

 

245,000

 

818,600

 

Exercised

 

(5,979

)

(78,751

)

(84,730

)

Cancelled

 

(1,026,659

)

—

 

(1,026,659

)

Outstanding, December 31, 2008

 

3,518,899

 

185,000

 

3,703,899

 

 

 

 

 

 

 

 

 

Granted

 

4,859,999

 

411,128

 

5,271,127

 

Exercised

 

(380,354

)

(510,182

)

(890,536

)

Cancelled

 

(2,086,525

)

(45,946

)

(2,132,471

)

Oustanding, December 31, 2009

 

5,912,019

 

40,000

 

5,952,019

 

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

EXACT SCIENCES CORPORATION

 

 

Date: July 2, 2010

By:

/s/ Maneesh Arora

 

 

Maneesh Arora

 

 

Senior Vice President and Chief Financial Officer

 

3